Workshop 20 January 2025
List of people who will participate at workshop for convergence environments. Will be updated.
Microbiology and antimicrobial resistance
Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial project idea |
---|---|---|
Camila Esguerra |
Disease models, Drug discovery, Tissue xenografting, Toxicology |
|
Osman Gani |
Computer-aided drug design (CADD). Molecular Modeling |
|
Reidar Lund |
- mechanisms of antimicrobial peptides |
Mechanism of action and encapsulation of antimicrobial peptides |
Ute Krengel |
Structural biology & infection biology |
Amyloids: Curse or Opportunity? – From Medicine to Cultural Heritage |
antimicrobial peptides, peptoids, drug delivery, self-assembly, structural characterization, antibiotics, antivirals, peptide-lipid interactions |
||
John N. Parker |
I am a sociologist of science with expertise in how to best create the kinds of organizations, groups, and social interactions that best facilitate creative interdisciplinary research. My interest is in joining a team to help them plan how they might best organize themselves for interdisciplinary success. |
|
Resistome, microbiome, AMR |
This project idea is to focus on harnessing the potential of microbiota modulation to combat antimicrobial resistance (AMR) within the framework of the One Health approach. By leveraging interventions such as probiotics, prebiotics, and microbiome-targeted therapies, we aim to restore microbial balance and reduce the spread of resistant pathogens across humans, animals, and the environment. |
|
Antimicrobial resistance development, Microbial comparative and functional genomics, Microbial evolution, Bacterial virulence mechanisms |
UiO AMR - Cross-faculty AMR research initiative (LSB-CE) |
|
Molecular microbiology, antimicrobial resistance, vaccine development, One health, animal health. |
Antimicrobial resistance is one of the major global health threats. Our research groups is interested in approaching this problem on different ways from to understand basic biological mechanisms to drug use and new antimicrobial strategies. |
|
The machinery of life - molecular mechanisms and organism biology
Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial project idea |
---|---|---|
Melinka Butenko |
Signalling systems, toxins, structural biology, peptide activity, plant pathogen interactions. |
|
Camila Esguerra |
Disease models, Drug discovery, Tissue xenografting, Toxicology |
|
Ute Krengel |
Structural biology & infection biology |
Amyloids: Curse or Opportunity? – From Medicine to Cultural Heritage |
Mathematical modeling, knowledge-driven machine learning, digital twins, personalized cancer therapies, biomarkers, genomics, medical imaging. |
Personalized cancer therapy integrating multi-type clinical data, biological experimentation, mechanistic mathematical models and artificial intelligence. |
|
John N. Parker |
I am a sociologist of science with expertise in how to best create the kinds of organizations, groups, and social interactions that best facilitate creative interdisciplinary research. My interest is in joining a team to help them plan how they might best organize themselves for interdisciplinary success. |
|
bioinformatics, 3D genome organization, epigenetics, mechanobiology, gene transcription regulation |
With an integrated computational approach, we will provide insight into the interactions between fundamental biological processes in gene expression across domains and in health and disease. |
|
Molecular microbiology, antimicrobial resistance, vaccine development, One health, animal health. |
Antimicrobial resistance is one of the major global health threats. Our research groups is interested in approaching this problem on different ways from to understand basic biological mechanisms to drug use and new antimicrobial strategies. |
|
Statistical learning/ machine learning (ML) and AI for translational and clinical cancer research, in particular for personalised cancer therapies. Integration of data from diverse sources (multi-omics, drug screens, clinical, imaging, genomics) for prediction of drug response and synergies in pharmacogenomic screens and of prognosis and treatment response in patients. Machine learning for small and noisy (biomedical) data, e.g. through integration of knowledge and structure in ML. |
AI and robotics for personalised cancer medicine: Next-generation pipelines and tools for overcoming drug resistance in cancer by studying the full dynamics and evolution of the tumor and its environment in large-scale screens, in vitro, in vivo and in silico. |
|
Digital life science
Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial project idea |
---|---|---|
Osman Gani |
Computer-aided drug design (CADD). Molecular Modeling |
|
Mathematical modeling, knowledge-driven machine learning, digital twins, personalized cancer therapies, biomarkers, genomics, medical imaging. |
Personalized cancer therapy integrating multi-type clinical data, biological experimentation, mechanistic mathematical models and artificial intelligence. |
|
computational biology, gene expression regulation, multi-omics, machine learning, AI, transcription factors |
With an integrated computational approach, we will provide insight into the interactions between fundamental biological processes in gene expression across domains and in health and disease. |
|
John N. Parker |
I am a sociologist of science with expertise in how to best create the kinds of organizations, groups, and social interactions that best facilitate creative interdisciplinary research. My interest is in joining a team to help them plan how they might best organize themselves for interdisciplinary success. |
|
bioinformatics, 3D genome organization, epigenetics, mechanobiology, gene transcription regulation |
With an integrated computational approach, we will provide insight into the interactions between fundamental biological processes in gene expression across domains and in health and disease. |
|
bioinformatics, computational biology, gene expression, health and disease |
Use computational approaches to unravel the interplay between the different layers involved in gene expression. |
|
J?rgen Sugar |
Neuroscience, Memory |
Attention is important for memory. How is attention formed in the brain and how is it used to successfully form memories? My idea is to record neural data in humans while they perform a memory task that is highly dependent on attention. |
Statistical learning/ machine learning (ML) and AI for translational and clinical cancer research, in particular for personalised cancer therapies. Integration of data from diverse sources (multi-omics, drug screens, clinical, imaging, genomics) for prediction of drug response and synergies in pharmacogenomic screens and of prognosis and treatment response in patients. Machine learning for small and noisy (biomedical) data, e.g. through integration of knowledge and structure in ML. |
AI and robotics for personalised cancer medicine: Next-generation pipelines and tools for overcoming drug resistance in cancer by studying the full dynamics and evolution of the tumor and its environment in large-scale screens, in vitro, in vivo and in silico. |
|
Rein Aasland |
bioinformatics, bioinformatics data, gene expression, gene regulation, chromosomes, epigenetics, evolution |
Use bioinformatics to how explore gene expression influences development and disease |
Bioethics
Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial project idea |
---|---|---|
Mathematical modeling, knowledge-driven machine learning, digital twins, personalized cancer therapies, biomarkers, genomics, medical imaging. |
Personalized cancer therapy integrating multi-type clinical data, biological experimentation, mechanistic mathematical models and artificial intelligence. |
|
John N. Parker |
I am a sociologist of science with expertise in how to best create the kinds of organizations, groups, and social interactions that best facilitate creative interdisciplinary research. My interest is in joining a team to help them plan how they might best organize themselves for interdisciplinary success. |
|
Statistical learning/ machine learning (ML) and AI for translational and clinical cancer research, in particular for personalised cancer therapies. Integration of data from diverse sources (multi-omics, drug screens, clinical, imaging, genomics) for prediction of drug response and synergies in pharmacogenomic screens and of prognosis and treatment response in patients. Machine learning for small and noisy (biomedical) data, e.g. through integration of knowledge and structure in ML. |
AI and robotics for personalised cancer medicine: Next-generation pipelines and tools for overcoming drug resistance in cancer by studying the full dynamics and evolution of the tumor and its environment in large-scale screens, in vitro, in vivo and in silico. |
|
No specified topic
Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial project idea |
---|---|---|